3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Pancreatic Neoplasms
3
Inflammation
2
Glioblastoma
2
Frailty
2
Recurrence
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Myofibroma
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hemorrhage
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anemia
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
luspatercept
2
vactosertib
1
ibrutinib
1
fludarabine phosphate
1
Taxes
1
Rituximab
1
Pluvicto
1
Pharmacogenomic Testing
1
Observation
1
Lenalidomide
1
Iron-Dextran Complex
1
Holistic Health
1
Gemcitabine
1
Epoetin Alfa
1
Cyclophosphamide
1
CT-P10
1
Biopsy
1
Ascorbic Acid
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia
×
Ascorbic Acid
×
1 year
×
Clear all
NCT06018883
2025-08-07
PTCA199-3
Fudan University
Phase 3
Active not recruiting
100 enrolled